WPW
EW icon

Winthrop Partners - WNY’s Edwards Lifesciences EW Stock Holding History

Winthrop Partners - WNY’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$70.4K Hold
960
– – 0.05% 166
2019
Q2 		$59.1K Hold
960
– – 0.04% 149
2019
Q1 		$60.8K Hold
960
– – 0.05% 144
2018
Q4 		$49K Hold
960
– – 0.05% 147
2018
Q3 		$55.7K Hold
960
– – 0.05% 167
2018
Q2 		$46.6K Hold
960
– – 0.04% 183
2018
Q1 		$44K Buy
+960
New +$41.7K 0.03% 223

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Winthrop Partners - WNY's EW Position: Q3 2019 in Review

Winthrop Partners - WNY held its Edwards Lifesciences (EW) position steady in Q3 2019 at 960 shares worth $70.4K. The position accounts for 0.05% of the portfolio, ranked #166.

Winthrop Partners - WNY first reported a position in EW in Q1 2018 and has held it in 7 quarters since. 964 funds tracked by Wall St. Rank hold EW as of Q3 2019.

  • Winthrop Partners - WNY held 960 shares of Edwards Lifesciences worth $70.4K as of Q3 2019.
  • Winthrop Partners - WNY left its Edwards Lifesciences share count unchanged in Q3 2019.
  • Edwards Lifesciences made up 0.05% of Winthrop Partners - WNY's portfolio in Q3 2019, its #166 holding.
  • Winthrop Partners - WNY first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 7 quarters since.
  • 964 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.